These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 27098189
1. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells. Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. Life Sci; 2016 May 15; 153():41-9. PubMed ID: 27098189 [Abstract] [Full Text] [Related]
2. Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells. Tusskorn O, Senggunprai L, Prawan A, Kukongviriyapan U, Kukongviriyapan V. BMC Cancer; 2013 Dec 05; 13():571. PubMed ID: 24304591 [Abstract] [Full Text] [Related]
3. Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway. Laothong U, Hiraku Y, Oikawa S, Intuyod K, Murata M, Pinlaor S. Oncol Rep; 2015 Mar 05; 33(3):1443-9. PubMed ID: 25606968 [Abstract] [Full Text] [Related]
5. The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines. Samatiwat P, Tabtimmai L, Suphakun P, Jiwacharoenchai N, Toviwek B, Kukongviriyapan V, Gleeson MP, Choowongkomon K. Asian Pac J Cancer Prev; 2021 Feb 01; 22(2):381-390. PubMed ID: 33639651 [Abstract] [Full Text] [Related]
6. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W. Tumour Biol; 2013 Dec 01; 34(6):3637-48. PubMed ID: 23832540 [Abstract] [Full Text] [Related]
7. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Aneknan P, Kukongviriyapan V, Prawan A, Kongpetch S, Sripa B, Senggunprai L. Asian Pac J Cancer Prev; 2014 Dec 01; 15(12):5071-6. PubMed ID: 24998588 [Abstract] [Full Text] [Related]
9. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. Tepsiri N, Chaturat L, Sripa B, Namwat W, Wongkham S, Bhudhisawasdi V, Tassaneeyakul W. World J Gastroenterol; 2005 May 14; 11(18):2748-53. PubMed ID: 15884115 [Abstract] [Full Text] [Related]
10. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. Srijiwangsa P, Ponnikorn S, Na-Bangchang K. BMC Pharmacol Toxicol; 2018 Jun 19; 19(1):32. PubMed ID: 29914576 [Abstract] [Full Text] [Related]
11. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. Buranrat B, Prawan A, Kukongviriyapan U, Kongpetch S, Kukongviriyapan V. World J Gastroenterol; 2010 May 21; 16(19):2362-70. PubMed ID: 20480521 [Abstract] [Full Text] [Related]
12. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. Samatiwat P, Prawan A, Senggunprai L, Kukongviriyapan U, Kukongviriyapan V. Tumour Biol; 2016 Aug 21; 37(8):11495-507. PubMed ID: 27015836 [Abstract] [Full Text] [Related]
13. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms. Guragain D, Seubwai W, Kobayashi D, Silsinivanit A, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Wongkham S, Araki N, Cha'on U. Cell Mol Biol (Noisy-le-grand); 2018 Jul 30; 64(10):113-118. PubMed ID: 30084802 [Abstract] [Full Text] [Related]
14. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. Hahnvajanawong C, Boonyanugomol W, Nasomyon T, Loilome W, Namwat N, Anantachoke N, Tassaneeyakul W, Sripa B, Namwat W, Reutrakul V. World J Gastroenterol; 2010 May 14; 16(18):2235-43. PubMed ID: 20458760 [Abstract] [Full Text] [Related]
15. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. Asgar MA, Senawong G, Sripa B, Senawong T. Int J Oncol; 2016 Jan 14; 48(1):409-20. PubMed ID: 26575528 [Abstract] [Full Text] [Related]
16. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W. Drug Des Devel Ther; 2020 Jan 14; 14():2319-2334. PubMed ID: 32606601 [Abstract] [Full Text] [Related]
17. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway. Wandee J, Prawan A, Senggunprai L, Kongpetch S, Tusskorn O, Kukongviriyapan V. Life Sci; 2018 Aug 15; 207():172-183. PubMed ID: 29847773 [Abstract] [Full Text] [Related]
18. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway. Wandee J, Prawan A, Senggunprai L, Kongpetch S, Kukongviriyapan V. Life Sci; 2019 Jan 15; 217():155-163. PubMed ID: 30528773 [Abstract] [Full Text] [Related]
19. Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species. Kittiratphatthana N, Kukongviriyapan V, Prawan A, Senggunprai L. J Pharm Pharmacol; 2016 Sep 15; 68(9):1184-92. PubMed ID: 27334841 [Abstract] [Full Text] [Related]
20. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis. Sakonsinsiri C, Kaewlert W, Armartmuntree N, Thanan R, Pakdeechote P. Cell Mol Biol (Noisy-le-grand); 2018 Jul 30; 64(10):28-33. PubMed ID: 30084792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]